Your search returned 3 results.

Results
	1.	FLT3-ITD-TKD dual mutants associated with AML confer resistance to FLT3 PTK inhibitors and cytotoxic agents by overexpression of Bcl-x(L). [electronic resource] by Bagrintseva, Ksenia Geisenhof, Stefanie Kern, Ruth Eichenlaub, Sabine Reindl, Carola Ellwart, Joachim W Hiddemann, Wolfgang Spiekermann, Karsten Producer: 20050607 In: Blood vol. 105 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Arginine 595 is duplicated in patients with acute leukemias carrying internal tandem duplications of FLT3 and modulates its transforming potential. [electronic resource] by Vempati, Sridhar Reindl, Carola Kaza, Seshu Kumar Kern, Ruth Malamoussi, Theodora Dugas, Martin Mellert, Gudrun Schnittger, Susanne Hiddemann, Wolfgang Spiekermann, Karsten Producer: 20070913 In: Blood vol. 110 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Transformation by oncogenic mutants and ligand-dependent activation of FLT3 wild-type requires the tyrosine residues 589 and 591. [electronic resource] by Vempati, Sridhar Reindl, Carola Wolf, Ulla Kern, Ruth Petropoulos, Konstantin Naidu, Vegi M Buske, Christian Hiddemann, Wolfgang Kohl, Tobias M Spiekermann, Karsten Producer: 20080916 In: Clinical cancer research : an official journal of the American Association for Cancer Research vol. 14 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)